CORD-19:c654596857bce9cdd64ffc51842048643107348c / 341753-341924
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/c654596857bce9cdd64ffc51842048643107348c","sourcedb":"CORD-19","sourceid":"c654596857bce9cdd64ffc51842048643107348c","text":"To assess whether antiretroviral therapy (ART) intensification, GM-CSF use and Remune initiation before stopping ART lead to viremia containment, and long periods off ART.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2935","span":{"begin":0,"end":171},"obj":"Sentence"},{"id":"T60185","span":{"begin":0,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T2935","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T60185","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T378","span":{"begin":0,"end":171},"obj":"Sentence"}],"attributes":[{"subj":"T378","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T741","span":{"begin":125,"end":132},"obj":"Phenotype"}],"attributes":[{"id":"A741","pred":"hp_id","subj":"T741","obj":"http://purl.obolibrary.org/obo/HP_0020071"},{"subj":"T741","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T411","span":{"begin":67,"end":70},"obj":"Body_part"}],"attributes":[{"id":"A411","pred":"uberon_id","subj":"T411","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"subj":"T411","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec9395","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93afec"},{"id":"CORD-19-PD-HP","color":"#c9ec93"},{"id":"CORD-19-PD-UBERON","color":"#ec93e3"}]}]}}